Kikuchi, S., Negoro, E., Horaguchi, R., Fujihira, T., Nabe, Y., Minemura, T., Ono, K., Kamihara, Y., Wada, A., Dang, N. H., Masaki, Y., Miyamoto, T., Yamauchi, T. and Sato, T. (2020) “Optimizing bone health in lymphoma survivors: denosumab superiority to alendronate for R-CHOP-like therapy (the DENOSULY phase III randomized controlled trial)”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.300564.